Clinical Trial: Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: A Multicenter, Randomized, Placebo-controlled, Double-blind, Dose-finding Phase 2 Clinical Trial to Evaluate the Efficacy in Reduction of Intraocular Pressure and Safety of PHP-201 in Patients With

Brief Summary: Evaluation of the optimal dose for the efficacy in reduction of intraocular pressure and safety of PHP-201 ophthalmic solution in patients with normal tension glaucoma

Detailed Summary: Data collection (electronic case report forms), Data dictionary (MedDRA)
Sponsor: pH Pharma

Current Primary Outcome: Mean diurnal IOP change from baseline at post-treatment time point of 4 weeks [ Time Frame: 4 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: The number of patient with adverse events [ Time Frame: 28 days ]

The number of patient with adverse events including ocular adverse events


Original Secondary Outcome: Same as current

Information By: pH Pharma

Dates:
Date Received: March 30, 2017
Date Started: March 6, 2017
Date Completion: December 2017
Last Updated: April 7, 2017
Last Verified: March 2017